ProfileGDS2971 / 2.4.20.9
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 44% 17% 56% 7% 59% 45% 57% 84% 62% 18% 77% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.044401644
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.55093217
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 20.085261156
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-1.594797
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.13644359
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)-0.10192945
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.12967357
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)0.83427984
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.21551662
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.66468518
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.50505677
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.20898133